Biocytogen and Sihuan partner to advance new therapeutics for weight loss
Pharmaceutical Business Review
Under the agreement, Biocytogen's fully human antibody discovery platform will be combined with Sihuan Pharmaceutical's capabilities in drug development, manufacturing, and commercialisation.
pharminent
April 2, 2026 (Last updated: April 2, 2026)
Pharmaceutical Business Review
Under the agreement, Biocytogen’s fully human antibody discovery platform will be combined with Sihuan Pharmaceutical’s capabilities in drug development, manufacturing, and commercialisation.